Skip to main content
SpringerLink
Log in

Why, When, and How to Prescribe a Combination of Antibiotics

  • Conference paper
Book cover Yearbook of Intensive Care and Emergency Medicine 1998

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 1998))

  • 194 Accesses

Abstract

The aim of antibiotic treatment is to cure infection, documented or not, while fulfilling, if possible, certain conditions: The lowest risk of toxicity; the lowest cost; and the least impact on bacterial ecology in order to limit the emergence of resistant strains.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moellering RC (1985) Can the third-generation cephalosporins eliminate the need for antimicrobial combinations? Am J Med (suppl 2A ): 104–109

    Article  Google Scholar 

  2. Eliopoulos GM, Moellering BC (1991) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine. Williams and Wilkins Co, Baltimore, pp 432–492

    Google Scholar 

  3. Denis JP, Gouin (1992) Association d’antibiotiques In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chirurgie. Arnette, Paris, pp 351–362

    Google Scholar 

  4. Dejace P, Klatersky J (1986) Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med 80 (suppl. 6B): 29–37

    Article  PubMed  CAS  Google Scholar 

  5. Barriere SL (1991) Monotherapy versus combination antimicrobial therapy. A review. Pharma-cotherapy 11: 645–654

    Google Scholar 

  6. Joly-Guillou ML, Bergogne-Berezin E (1986) Synergies ou antagonismes des associations d’anti-biotiques. Presse Med 15: 1037–1040

    PubMed  CAS  Google Scholar 

  7. Regnier B (1987) Utilisation des associations d’antibiotiques. Presse Med 16: 2186–2191

    PubMed  CAS  Google Scholar 

  8. Martin C, Perrin G, Lambert D (1992) Les quinolones. In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chirurgie. Arnette, Paris, pp 109–112

    Google Scholar 

  9. Martin C, Gouin F, Fourrier F, Juninger W, Prieur BL (1988) Pefloxacin in the treatment of noso-comial lower respiratory tract infections in intensive care patients. J Antimicrob Chemother 21: 795–799

    Article  PubMed  CAS  Google Scholar 

  10. Pechere JC, Marchou B, Michea-Hamlehpour M, Aukenthaler A (1986) Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother 17 (suppl A) 11–18

    Google Scholar 

  11. Michea-Hamzehpour M, Pechere JC, Marchou B, Auckenthaler RC (1986) Combination therapy: a way to limit the emergence of resistance. Am J Med 80 (suppl 6B): 138–142

    Article  PubMed  CAS  Google Scholar 

  12. Boogaerts MA (1995) Anti-infective strategies in neutropenia. J Antimicrob Chemother 36 (suppl A): 167–178

    PubMed  CAS  Google Scholar 

  13. Perronne C, Regnier B, Legrand P, et al (1986) Echec des nouvelles béta-lactamines dans le traitement d’infections sévères Enterobacter cloacae. Presse Med 15: 1813–1818

    PubMed  CAS  Google Scholar 

  14. Anonymous (1991): Respiratory infections of the lower respiratory airway. 4th Consensus Conference of the French Society of Infectious Diseases. Med Mai Inf 21 (suppl 1): 1–8

    Article  Google Scholar 

  15. Niederman MS, Bass JB, Campbell GD, et al (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 142: 1418–1426

    Google Scholar 

  16. American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 143: 1711–1725

    Google Scholar 

  17. Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson S, Page CP (1992) Guidelines for clinical care: anti-infective agents for intra-abdominal infections. Arch Surg 127: 83–89

    Article  PubMed  CAS  Google Scholar 

  18. Geroulanos SJ and the Meropenem Study Group (1995) Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. J Antimicrob Chemother 36 (suppl A): 191–205

    Google Scholar 

  19. Huizinga WKJ, Warren BL, Baker LW, et al (1995) Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections. J Antimicrob Chemother 36 (suppl A): 79–89

    Google Scholar 

  20. Cometta A, Baumgartner JD, Lew D, et al (1994) Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for the treatment of severe infections in non- neutropenic patients. Antimicrob Agents Chemother 38: 1309–1313

    PubMed  CAS  Google Scholar 

  21. Winston DJ, Mc Grattan MA, Busuttil RW (1984) Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections. Antimicrob Agents Chemother 26: 673–677

    PubMed  CAS  Google Scholar 

  22. Croce MA, Fabian TC, Stewart RM, et al (1993) Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 35: 303–309

    Article  PubMed  CAS  Google Scholar 

  23. Solberg CO, Sjursen H (1995) Safety and efficacy of meropenem in patients with septicemia: a randomised comparison with ceftazidime, alone or combined with amikacin. J Antimicrob Chemother 36 (suppl A): 157–166

    Article  PubMed  CAS  Google Scholar 

  24. Norrby SR, Finch RG, Glauser M, et al (1993) Monotherapy of serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. J Antimicrob Chemother 31: 927–937

    Article  PubMed  CAS  Google Scholar 

  25. Cometta A, Calandra T, Gaya H, et al (1996) Monotherapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40: 1108–1115

    PubMed  CAS  Google Scholar 

  26. Leibovici L, Paul M, Poznanski O, et al (1997) Monotherapy versus ß-lactam-aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study. Anti-microb Agents Chemother 41: 1127–1133

    CAS  Google Scholar 

  27. Martin C (1992) Rapports thérapeutiques (taux tissulaires/CMI 90). In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chirurgie. Arnette, Paris, pp 717–741

    Google Scholar 

  28. Fantin B, Carbon C (1992) In vivo antibiotic synergism: contribution of animal models. Anti-microb Agents Chemother 36: 907–912

    CAS  Google Scholar 

  29. Mallet MN (1992) Bactériostase, bactéricidie, étude des associations d’antibiotiques. In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chirurgie. Arnette, Paris, pp 281–304

    Google Scholar 

  30. Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ (1989) Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Anti-microb Agents Chemother 33: 1184–1187

    CAS  Google Scholar 

  31. Acar JF, Goldstein FW, Duval J (1983) Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. Rev Infect Dis 5 (suppl 3): 502–506

    Article  Google Scholar 

  32. Bayer AS, Lam KJ (1985) Efficacy of vancomycin plus rifampicin in experimental aortic valve - endocarditis due to methicillin-resistant Staph aureus: in vitro — in vivo correlations. J Infect Dis 151: 157–165

    Article  PubMed  CAS  Google Scholar 

  33. Norden CW, Shaffer M (1983) Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycin and rifampin. J Infect Dis 147: 352–357

    Article  PubMed  CAS  Google Scholar 

  34. Wispelwey B, Scheid WM (1990) Brain abcess. In: Mandell GL, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 777–787

    Google Scholar 

  35. Caron F, Carbon C, Gutmann L (1991) Evaluation of the triple combination penicillin-vanco- mycin-gentamicin in an experimental endocarditis caused by moderately penicillin and a highly glycopeptide-resistant strain of Enterococcus faecium. J Infect Dis 164: 888–893

    Article  PubMed  CAS  Google Scholar 

  36. Klatersky J, Zinners SH (1982) Synergistic combinations of antibiotics in Gram-negative bacillary infections. Rev Infect Dis 4: 294–301

    Article  Google Scholar 

  37. Sande MA, Irvin RG (1975) Penicillin-aminoglycoside synergism in experimental Streptococcus vidans endocarditis. J Infect Dis 136: 327–335

    Google Scholar 

  38. Sande MA, Courtney KB (1976) Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 88: 118–124

    PubMed  CAS  Google Scholar 

  39. Wilson WR (1987) Antimicrobial therapy of streptococcal endocarditis. J Antimicrob Chemother 20 (suppl A): 147–159

    Article  PubMed  Google Scholar 

  40. Henry NK, Wilson WR, Geraci JE (1986) Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrob Agents Chemother 30: 725–728

    PubMed  CAS  Google Scholar 

  41. Levine DP, Cushing RD, Jui J, Brown WJ (1982) Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 97: 330–338

    PubMed  CAS  Google Scholar 

  42. Korzeniowski O, Sande MA and the NCESG (1982) Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non addicts. Ann Inter Med 97: 496–504

    CAS  Google Scholar 

  43. Rahal JJ (1986) Treatment of methicillin-resistant staphylococcal infection. In: Peterson PK, Verhoef J (eds) The antimicrobial agents annual I. Elsevier, Amsterdam, pp 489–514

    Google Scholar 

  44. Reyes MP, Lerner AM (1983) Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis 5: 314–321

    Article  PubMed  CAS  Google Scholar 

  45. Martin C, Saux P, Perrin G (1992) Choix d’une antibiothérapie pour le traitement d’une infection à Pseudomonas. In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chirurgie. Arnette, Paris, pp 389–406

    Google Scholar 

  46. Quinn JP, Dubek EJ, Divincenzo CA, Lucks DA, Lerner SA (1986) Emergence of resistance to imipenem during therapy for Pseudomonas infection. J Infect Dis 16: 289–294

    Article  Google Scholar 

  47. Nichols L, Maki DG (1985) The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Chemotherapia 4: 102–109

    CAS  Google Scholar 

  48. Martin C, Albanèse J, Thomachot L, Quinio B (1993) Choix d’une antibiothérapie pour le traitement d’une infection staphylocoques. In: Conférences d’actualisation 35e Congrès National d’Anesthésie et Réanimation. Masson, Paris, pp 601–620

    Google Scholar 

  49. Saux P, Martin C, Perrin G (1992) La fosfomycine. In: Martin C, Gouin F (eds) Antibiothérapie en réanimation et en chinurgie. Arnette, Paris, pp 189–194

    Google Scholar 

  50. Chow JW, Fine MJ, Shlaes DM (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115: 585–590

    PubMed  CAS  Google Scholar 

  51. Gribble M J, Chow AW, Naiman SC, et al (1983) Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob Agents Chemother 24: 388–393

    PubMed  CAS  Google Scholar 

  52. Fink MP, Snydman DR, Niederman MS (1994) Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double blind trial comparing intravenous ciprofloxacin with imipenem-cilastin. Antimicrob Agents Chemother 38: 547–557

    PubMed  CAS  Google Scholar 

  53. Thabaut A (1992) Imipénème: Monotherapie ou associations? Arguments microbiologiques. Lettre Infect 7: 151–153

    Google Scholar 

  54. Hilf M, Yu VL, Sharp J, et al (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlation in a prospective study of 200 patients. Am J Med 87: 540–546

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. X. Viviand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Arnaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Clinical Director) (Clinical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Viviand, X., Arnaud, S., Martin, C. (1998). Why, When, and How to Prescribe a Combination of Antibiotics. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1998. Yearbook of Intensive Care and Emergency Medicine, vol 1998. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72038-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72038-3_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63798-1

  • Online ISBN: 978-3-642-72038-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation